Related Experiment Video
Updated: Jul 28, 2025
08:55
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
16.3K
Cancer cachexia - adopting a systems wide approach
Judith Sayers1,2,3, Richard Je Skipworth3, Barry Ja Laird1,2
1St Columba's Hospice.
Summary
Cancer cachexia, a condition causing 2 million deaths yearly, lacks effective therapies. Understanding its multisystem effects beyond muscle loss is key to developing new treatments.
Area of Science:
- Oncology
- Physiology
- Pathology
Background:
- Cancer cachexia is a complex syndrome responsible for millions of deaths annually, yet lacks a standard treatment.
- Current understanding is limited by definitional ambiguity and a narrow focus on muscle wasting.
- Systemic inflammation is increasingly recognized as a central factor in cachexia's pathology.
Approach:
- This review examines the extra-muscular features and multisystem interactions in cancer cachexia.
- It highlights the importance of considering adipose tissue, liver, brain, gut, and heart involvement.
- The review advocates for a shift in focus beyond solely muscle-related symptoms.
Key Points:
- Cachexia affects multiple organs, including adipose tissue, liver, brain, gut, and heart.
- Systemic inflammation plays a crucial role in unifying the diverse manifestations of cachexia.
- A comprehensive understanding requires investigating these multisystem interactions.
Conclusions:
- Robust patient characterization is essential for deciphering cachexia's clinical phenotypes and underlying mechanisms.
- Moving beyond a muscle-centric view is critical for advancing cachexia research.
- Developing multimodal treatment strategies necessitates a holistic understanding of this devastating condition.
Related Concept Videos
01:21Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
02:49Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K